Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis

In the recent decade, the importance of DNA damage repair (DDR) and its clinical application have been firmly recognized in prostate cancer (PC). For example, olaparib was just approved in May 2020 to treat metastatic castration-resistant PC with homologous recombination repair-mutated genes; howeve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pai-Chi Teng, Shu-Pin Huang, Chia-Hsin Liu, Ting-Yi Lin, Yi-Chun Cho, Yo-Liang Lai, Shu-Chi Wang, Hsin-Chih Yeh, Chih-Pin Chuu, Deng-Neng Chen, Wei-Chung Cheng, Chia-Yang Li
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/86ef3631092c42d48c72b27ec1f85b11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:86ef3631092c42d48c72b27ec1f85b11
record_format dspace
spelling oai:doaj.org-article:86ef3631092c42d48c72b27ec1f85b112021-11-11T17:13:27ZIdentification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis10.3390/ijms2221117711422-00671661-6596https://doaj.org/article/86ef3631092c42d48c72b27ec1f85b112021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11771https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067In the recent decade, the importance of DNA damage repair (DDR) and its clinical application have been firmly recognized in prostate cancer (PC). For example, olaparib was just approved in May 2020 to treat metastatic castration-resistant PC with homologous recombination repair-mutated genes; however, not all patients can benefit from olaparib, and the treatment response depends on patient-specific mutations. This highlights the need to understand the detailed DDR biology further and develop DDR-based biomarkers. In this study, we establish a four-gene panel of which the expression is significantly associated with overall survival (OS) and progression-free survival (PFS) in PC patients from the TCGA-PRAD database. This panel includes <i>DNTT</i>, <i>EXO1</i>, <i>NEIL3</i>, and <i>EME2</i> genes. Patients with higher expression of the four identified genes have significantly worse OS and PFS. This significance also exists in a multivariate Cox regression model adjusting for age, PSA, TNM stages, and Gleason scores. Moreover, the expression of the four-gene panel is highly correlated with aggressiveness based on well-known PAM50 and PCS subtyping classifiers. Using publicly available databases, we successfully validate the four-gene panel as having the potential to serve as a prognostic and predictive biomarker for PC specifically based on DDR biology.Pai-Chi TengShu-Pin HuangChia-Hsin LiuTing-Yi LinYi-Chun ChoYo-Liang LaiShu-Chi WangHsin-Chih YehChih-Pin ChuuDeng-Neng ChenWei-Chung ChengChia-Yang LiMDPI AGarticleprostate cancer (PC)DNA damage repair (DDR)DDR-based transcriptomic biomarkerprognostic markercancer survivalBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11771, p 11771 (2021)
institution DOAJ
collection DOAJ
language EN
topic prostate cancer (PC)
DNA damage repair (DDR)
DDR-based transcriptomic biomarker
prognostic marker
cancer survival
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle prostate cancer (PC)
DNA damage repair (DDR)
DDR-based transcriptomic biomarker
prognostic marker
cancer survival
Biology (General)
QH301-705.5
Chemistry
QD1-999
Pai-Chi Teng
Shu-Pin Huang
Chia-Hsin Liu
Ting-Yi Lin
Yi-Chun Cho
Yo-Liang Lai
Shu-Chi Wang
Hsin-Chih Yeh
Chih-Pin Chuu
Deng-Neng Chen
Wei-Chung Cheng
Chia-Yang Li
Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
description In the recent decade, the importance of DNA damage repair (DDR) and its clinical application have been firmly recognized in prostate cancer (PC). For example, olaparib was just approved in May 2020 to treat metastatic castration-resistant PC with homologous recombination repair-mutated genes; however, not all patients can benefit from olaparib, and the treatment response depends on patient-specific mutations. This highlights the need to understand the detailed DDR biology further and develop DDR-based biomarkers. In this study, we establish a four-gene panel of which the expression is significantly associated with overall survival (OS) and progression-free survival (PFS) in PC patients from the TCGA-PRAD database. This panel includes <i>DNTT</i>, <i>EXO1</i>, <i>NEIL3</i>, and <i>EME2</i> genes. Patients with higher expression of the four identified genes have significantly worse OS and PFS. This significance also exists in a multivariate Cox regression model adjusting for age, PSA, TNM stages, and Gleason scores. Moreover, the expression of the four-gene panel is highly correlated with aggressiveness based on well-known PAM50 and PCS subtyping classifiers. Using publicly available databases, we successfully validate the four-gene panel as having the potential to serve as a prognostic and predictive biomarker for PC specifically based on DDR biology.
format article
author Pai-Chi Teng
Shu-Pin Huang
Chia-Hsin Liu
Ting-Yi Lin
Yi-Chun Cho
Yo-Liang Lai
Shu-Chi Wang
Hsin-Chih Yeh
Chih-Pin Chuu
Deng-Neng Chen
Wei-Chung Cheng
Chia-Yang Li
author_facet Pai-Chi Teng
Shu-Pin Huang
Chia-Hsin Liu
Ting-Yi Lin
Yi-Chun Cho
Yo-Liang Lai
Shu-Chi Wang
Hsin-Chih Yeh
Chih-Pin Chuu
Deng-Neng Chen
Wei-Chung Cheng
Chia-Yang Li
author_sort Pai-Chi Teng
title Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
title_short Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
title_full Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
title_fullStr Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
title_full_unstemmed Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
title_sort identification of dna damage repair-associated prognostic biomarkers for prostate cancer using transcriptomic data analysis
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/86ef3631092c42d48c72b27ec1f85b11
work_keys_str_mv AT paichiteng identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT shupinhuang identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT chiahsinliu identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT tingyilin identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT yichuncho identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT yolianglai identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT shuchiwang identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT hsinchihyeh identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT chihpinchuu identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT dengnengchen identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT weichungcheng identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
AT chiayangli identificationofdnadamagerepairassociatedprognosticbiomarkersforprostatecancerusingtranscriptomicdataanalysis
_version_ 1718432129009844224